BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
BEGIN:VEVENT
DTSTAMP:20260617T053929Z
UID:7b4d04d3-b2c8-4a5d-ad60-8a67c90e6f98
DTSTART:20160616T090000Z
DTEND:20160617T000000Z
DESCRIPTION:Gene editing\, particularly using the CRISPR (Clustered Regular
 ly Interspaced Short Palindromic Repeats)/Cas9 system\, is now being exten
 sively used as a research and functional screening tool in drug discovery.
  Cambridge Healthtech Institute’s second annual conference on Translatio
 nal Gene Editing will bring together experts from all aspects of preclinic
 al research\, from early target discovery to drug delivery\, to talk about
  the progress being made in gene editing and how it’s being applied. Lea
 rn about ways in which CRISPR/Cas9 is being used to identify targets\, cre
 ate relevant cell lines and in vivo disease models\, set up functional scr
 eens\, and for targeted drug delivery. What can you do to overcome some of
  the inherent challenges with design\, delivery and off-target effects ass
 ociated with CRISPR/Cas9? Hear from experts in pharma/biotech\, academic a
 nd government labs who will share their experiences leveraging the utility
  of gene editing for diverse applications\, particularly in oncology and i
 mmunotherapy.\n
LOCATION:Westin Boston Waterfront
SUMMARY:2nd Annual Translational Gene Editing
URL;VALUE=URI:http://www.worldpreclinicalcongress.com/Gene-Editing/
END:VEVENT
END:VCALENDAR